Related Experiment Video
Updated: Aug 3, 2026
12:08
Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
A pharmacodynamic approach to optimizing insulin therapy
1Laboratory of Theoretical and Physical Biology, National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD 20892.
Computer Methods and Programs in Biomedicine
|April 1, 1991
Summary
GLUCOJECT optimizes insulin therapy for diabetes by simulating glucose and insulin levels. This program helps find the best insulin regimen to maintain ideal blood glucose control for patients.
Area of Science:
- Biomedical Engineering
- Endocrinology
- Computational Biology
Background:
- Insulin-dependent diabetes requires careful management of glucose and insulin levels.
- Accurate simulation of insulin pharmacokinetics and glucose dynamics is crucial for effective therapy.
Purpose of the Study:
- To develop and present GLUCOJECT, a program for simulating and optimizing insulin therapy in diabetic patients.
- To provide a tool for calculating ideal insulin profiles based on individual patient data.
Main Methods:
- Utilized a simplified physiologic model for subcutaneous insulin absorption, clearance, and glucose utilization.
- Integrated self-monitored glucose and insulin dose data from memory meters.
- Employed a least-squares criterion to identify optimal insulin regimens from various combinations of insulin types.
Main Results:
- GLUCOJECT reconstructs typical daily glucose and insulin profiles.
- The program calculates glucose utilization rates and endogenous/exogenous glucose entry.
- It predicts plasma glucose levels for optimized insulin regimens.
Conclusions:
- GLUCOJECT offers a potential method for optimizing insulin therapy in insulin-dependent diabetes.
- The program can serve as an educational tool for patients and healthcare professionals.
- It may assist in the clinical management of diabetes by identifying personalized insulin strategies.
Related Concept Videos
01:20Measurement of Bioavailability: Pharmacodynamic Methods
Pharmacodynamic methods provide insights into a drug's effects on physiological processes over time and play a crucial role in understanding bioavailability and therapeutic efficacy. These methods can be broadly classified into acute pharmacological and therapeutic response approaches, each with distinct mechanisms and applications.The acute pharmacological response method directly correlates a drug's physiological effects, such as ECG or pupil diameter changes, to its time course in the body.
01:24Dosage Regimen: Individualization
Individualization in dosing regimens is the customization of medication doses for individual patients. Its necessity arises from the goal of maximizing therapeutic benefits while minimizing risks. This approach is pivotal because human responses to drugs can vary widely; what is effective for one person may be inadequate or excessive for another. Interpatient (intersubject) variability refers to differences in drug responses between individuals, while intrapatient (intrasubject) variability...
01:24Pharmacokinetic–Pharmacodynamic Relationship: Problems
The empirical approach to drug therapy optimization relies on correlating pharmacological response with administered dosage. Such an approach can be costly, time-consuming, and often yields poor correlation due to variables like formulation factors and drug elimination characteristics. A more precise approach correlates response with plasma drug concentration or the amount of drug in the body, rather than dosage. This is achieved through pharmacokinetic-pharmacodynamic (PK/PD) modeling, which...
01:15Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure (CHF).
01:27Insulin Formulations: Types and Delivery
Insulin preparations are categorized by their duration of action into short-acting and long-acting types. Two strategies are used to modify insulin's absorption and pharmacokinetic profile: slowing the absorption post-subcutaneous injection, or altering human insulin's amino acid sequence or protein structure. These changes retain the insulin's ability to bind to the insulin receptor, but alter its behavior in solution or after injection.
Short-acting insulins are divided into rapid-acting...
Short-acting insulins are divided into rapid-acting...
01:16Insulin: Dosing Regimen and Adverse Effects
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...